373
Views
24
CrossRef citations to date
0
Altmetric
Original

Cerebrovascular disease basis of depression: Post-stroke depression and vascular depression

, &
Pages 433-441 | Published online: 11 Jul 2009

References

  • Agrell B, Dehlin O. Depression in stroke patients with left and right hemisphere lesions: A study in geriatric rehabilitation inpatients. Aging 1994; 6: 49–56
  • Alexopoulos GS, Meyers BS, Young RC, Mattis S, Kakuma T. The course of geriatric depression with ‘reversible dementia’: A controlled study. The American Journal of Psychiatry 1991; 150: 1693–1699
  • Alexopoulos GS, Young RC, Meyers BS. Geriatric depression: Age of onset and dementia. Biological Psychiatry 1993; 34: 141–145
  • Alexopoulos GS, Meyers BS, Young RC, Campbell S, Silbersweig D, Charlson M. Vascular depression hypothesis. Archives of General Psychiatry 1997a; 54: 915–922
  • Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Sibersweig D, Charlson M. Clinically defined vascular depression. The American Journal of Psychiatry 1997b; 154: 562–565
  • Alexopoulos GS, Raue P, Arean P. Problem-solving therapy vs supportive therapy in geriatric depression with executive dysfunction. American Journal of Geriatric Psychiatry 2003; 11: 46–52
  • Andersen G, Vestergaard K, Ingermann-Nielsen M, et al. Risk factors for post-stroke depression. Acta Psychiatrica Scandinavica 1995; 92: 193–198
  • Andersen G, Vestergaard K, Lauritzen L. Effective treatment of post-stroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke 1994; 25: 1099–104
  • Astrom M, Adlofsson R, Asplund K. Major depression in stroke patients: A 3-year longitudinal study. Stroke 1993; 24: 976–982
  • Baldwin R. Is vascular depression a distinct sub-type of depressive disorder? A review of causal evidence. International Journal of Geriatric Psychiatry 2005; 20: 1–11
  • Bhogal SK, Teasell R, Foley N, Speechley M. Lesion location and post-stroke depression: Systematic review of the methodological limitations in the literature. Stroke 2004; 35: 794–802
  • Bleuler E. Textbook of psychiatry. Macmillan, New York 1951
  • Bolla-Wilson K, Robinson RG, Starkstein SE, Boston J, Price TR. Lateralization of dementia of depression in stroke patients. American Journal of Psychiatry 1989; 146: 627–634
  • Bonita R. Epidemiology of stroke. Lancet 1992; 339: 342–344
  • Brodaty H, Luscombe G, Anstey KJ, et al. Neuropsychological performance and dementia in depressed patients after 25 year follow-up: A controlled study. Psychology & Medicine 2003; 33: 1263–1275
  • Bryer JP, Starkstein SE, Votypka V, Parkh RM, Price TR, Robinson RG. Reduction of CSF monamine metabolites in post-sroke depression: A preliminary report. Journal of Neuropsychiatry& Clinical Neuroscience 1992; 4: 440–442
  • Burvill P, Johnson G, Jamrozik K, et al. Risk factors for post-stroke depression. International Journal of Geriatric Psychiatry 1997; 12: 219–226
  • Bush BA. Major life events as risk factors for post-stroke depression. Brain Injury 1999; 13: 131–137
  • Carson AJ, MacHale S, Allen K, Lawrie SM, Dennis M, House A, et al. Depression after stroke and lesion location: A systematic review. Lancet 2000; 356: 122–126
  • Cervilla J, Prince M, Richards M, et al. Vascular disease risk factors as determinants of incident depressive symptoms: A prospective, community-based study. Psychology & Medicine 2004; 35: 635–641
  • Coffey CE, Figiel GS, Djang WT, et al. Subcortical hyperintensity on magnetic resonance imaging: A comparison of normal and depressed elderly subjects. The American Journal of Psychiatry 1990; 147: 187–189
  • De Groot JC, de Leeuw F-E, Oudkertk M, Hofman A, Jolles J, Breteler MMB. Cerebral white matter lesions and depressive symptoms in elderly adults. Archives of General Psychiatry 2000; 57: 1071–1076
  • Eaton WW, Anthony JC, Gallo J, Cai T, Tien A, Romanoski A, et al. Natural history of Diagnostic Interview Schedule/DSM IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Archives of General Psychiatry 1997; 54: 993–999
  • Eaton WW, Kramer M, Anthony JC, Dryman A, Shapiro S, Locke BZ. The incidence of specific DIS/DSM-III mental disorders: Data from the NIMH Epidemiologic Catchment Area Program. Acta Psychiatrica Scandinavica 1989; 179: 163–178
  • Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. American Journal of Neuroradiology 1987; 149: 351–356
  • Figiel GS, Krishnan KRR, Doraiswamy PM, et al. Subcortical hyperintensities on brain magnetic resonance imaging: A comparison between late-age onset and early-onset elderly depressed subjects. Neurobiololgy of Aging 1991; 12: 245–247
  • Fujikawa T, Yamawaki S, Toubouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke 1993; 24: 1631–1634
  • Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. The British Journal of Psychiatry 1999; 175: 163–167
  • Gaupp R. Depressive states in old age. Classic Text 42 (orig. published 1905). Historical Psychiatry 2000; 11: 213–225
  • Hermann N, Black S, Lawrence J, Szekely C, Szalai J. The Sunnybrook Stroke Study: A prospective study of depressive symptoms and functional outcome. Stroke 1998; 29: 618–624
  • Hickie I, Scott E, Mitchell P, et al. Subcortical hyperintensities on magnetic resonance imaging: Clinical correlates and prognostic significance in patients with severe depression. Biological Psychiatry 1995; 37: 151–160
  • Jacoby RJ, Levy R. Computed tomography in the elderly. 3. Affective disorder. The British Journal of Psychiatry 1980; 136: 270–275
  • Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and post-stroke depression: A placebo-controlled trial of antidepressants. American Journal of Psychiatry 2003; 160: 1823–1829
  • Kalayam B, Meyers BS, Kakuma T, et al. Age at onset of geriatric depression and sensorineural hearing deficits. Biological Psychiatry 1995; 38: 649–658
  • Kales HC, Maixner DF, Mellow AM. Cerebrovascular disease and late-life depression. American Journal of Geriatric Psychiatry 2005; 2005: 88–98
  • Kraepelin E. Manic depressive insanity and paranoia. E & S Livingstone, Edinburgh 1921
  • Kramer-Ginsberg E, Greenwald BS, Krishnan KR, Christiansen B, Hu J, Ashtari M, et al. Neuropsychological functioning and MRI signal hyperintensities in geriatric depression. The American Journal of Psychiatry 1999; 156: 438–444
  • Krishnan KR, Taylor WD, McQuoid DR, MacFall JR, Payne ME, Provenzale JM, et al. Clinical characteristics of magnetic resonance imaging—defined subcortical ischemic depression. Biological Psychiatry 2004; 55: 390–397
  • Krishnan KRR, Goli V, Ellinwood EH. Leukoencephalopahty in patients diagnosed as major depressive. Biological Psychiatry 1988; 23: 519–522
  • Leetjens AF, Aben I, Lodder J, Verhey FR. General and disease-specific risk factors for depression after ischemic stroke: A two-step Cox regression analysis. International Psychogeriatrics 2006; Jun 29: 1–9, [Epub ahead of print]
  • Levy RM, Steffens DC, McQuoid DR, Provenzale JM, MacFall JR, Krishnan KR. MRI lesion severity and mortality in geriatric depression. American Journal of Geriatric Psychiatry 2003; 11: 678–682
  • Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: A double-blind study. Lancet 1984; 1(8372)297–300
  • Lipsey JR, Spencer WC, Rabins PV, Robinson RG. Phenomenological comparison of post-stroke depression and functional depression. The American Journal of Psychiatry 1986; 143: 527–529
  • Lockwood KA, Alexopoulos GS, van Gorp WG. Executive dysfunction in geriatric depression. The American Journal of Psychiatry 2002; 159: 1119–1126
  • Lyness JM, Caine ED, Cox C, et al. Cerebrovascular risk factors and later-life major depression. The American Journal of Geriatric Psychiatry 1998; 6: 5–13
  • Lyness JM, Caine ED, King DA, et al. Cerebrovascular risk factors and depression in older primary care patients. The American Journal of Geriatric Psychiatry 1999; 7: 252–258
  • Lyness JM, King DA, Conwell Y, et al. Cerebrovascular risk factors and 1-year depression outcome in older primary care patients. The American Journal of Psychiatry 2000; 257: 1499–1501
  • Mast BT, MacNeill SE, Lichtenberg PA. Post-stroke and clinically-defined vascular depression in geriatric rehabilitation patients. The American Journal of Geriatric Psychiatry 2004; 12: 84–92
  • Mayberg HS, Robinson RG, Wong DF, Parickh R, Bolduc P, Starkstein SE, et al. PET imaging of cortical S2 serotonin receptors after stroke: Lateralized changes relationship to depression. American Journal of Psychiatry 1988; 45: 937–943
  • Miller MD, Lenze EJ, Dew MA, et al. Effect of cerebrovascular risk factors on depression treatment outcome in later life. The American Journal of Geriatric Psychiatry 2002; 10: 592–598
  • Morris P, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. International Journal of Psychiatric Medicine 1990; 20: 349–364
  • Narushima K, Kosier JT, Robinson RG. Preventing of post-stroke depression: A 12-week double-blind randomized treatment trial with 21-month follow-up. Journal of Nervous & Mental Disorders 2002; 190: 296–303
  • Narushima K, Kosier JT, Robinson RG. A reappraisal of post-stroke depression, intra and inter-hemispheric lesion location using meta-analysis. Journal of Neuropsychiatry & Clinical Neuroscience 2003; 15: 422–430
  • Nebes RD, Vora IJ, Meltzer CC, Fukui MB, Williams RL, Kamboh MI, et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. The American 2001; 158: 878–884
  • O’Brien J, Desmond P, Ames D, Schweitzer I, Harrigan S, Tress B. A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease. British Journal of Psychiatry 1996; 168: 477–485
  • O’Brien J, Ames D, Chiu E, Schweitzer I, Desmond P, Tress B. Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: Follow-up study. British Medical Journal 1998; 317: 982–984
  • Palomaki H, Kaste M, Berg A, Lonnqvist R, Lonnqvist J, Lhtihalmes M, et al. Prevention of poststroke depression: One year randomized placebo controlled double blind trial of mianserin with 6-month follow-up after therapy. Journal of Neurology, Neurosurgery & Psychiatry 1999; 66: 490–494
  • Paoloucci S, Antonucci G, Pratesi L, et al. Post-stroke depression and its role in rehabilitation of inpatients. Archives of Physical Medicine and Rehabilitation 1999; 80: 985–990
  • Paradiso S, Ohkubo T, Robinson RG. Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke. International Journal of Psychiatry & Medicine 1997; 27: 137–157
  • Parikh R, Robinson R, Lipsey J, Starkstein S, Fedoroff J, Price T. The impact of post-stroke depression on recovery in activities of daily living over a two-year follow-up. Archives of Neurology 1990; 47: 785–789
  • Provinciali L, Coccia M. Post-stroke and vascular depression: A critical review. Neurological Sciences 2002; 22: 417–428
  • Rapp MA, Dahlman K, Sano M, Grossman MT, Haroutunian V, Gorman JM. Neuropsychological differences between late-onset and recurrent geriatric major depression. The American Journal of Psychiatry 2005; 162: 691–698
  • Rassmussen A, Lunde M, Pousen DL, Sorensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 2003; 44: 216–221
  • Robinson RG, Shoemaker WJ, Schlumpf M, Valk T, Bloom FE. Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature 1975; 255: 332–334
  • Robinson RG, Kubos KL, Starr LK, et al. Mood disorders in stroke patients: Importance of location of lesion. Brain 1984; 107(Pt 1)81–93
  • Robinson RG, Lipsey JR, Rao K, Price TR. Two-year longitudinal study of post-stroke mood disorders: Comparison of acute-onset with delayed onset depression. American Journal of Psychiatry 1986; 143: 1238–1244
  • Robinson RG, Schutz SK, Castillo C, Kopel T, Kosier T. Nortriptyline vs fluoxetine in the treatment of depression and in short term recovery after stroke: A placebo controlled, double-blind study. American Journal of Psychiatry 2000; 157: 351–359
  • Robinson RG. Post-stroke depression: Prevalence, diagnosis, treatment and disease progression. Biological Psychiatry 2003; 54: 376–387
  • Robinson RG. Vascular depression and post-stroke depression: Where do we go from here?. The American Journal of Geriatric Psychiatry 2005; 13: 85–87
  • Schwartz JA, Speed NM, Brunberg JA, et al. Depression in stroke rehabilitation. Biological Psychiatry 1993; 33: 694–699
  • Schweitzer I, Tuckwell V, O’Brien J, Ames D. Is late onset depression a prodrome to dementia?. International Journal of Geriatric Psychiatry 2002; 17: 997–1005
  • Starkstein SE, Robinson RG, Price TR. Comparison of cortical and subcortical lesions in the production of post-stroke mood disorders. Brain 1987; 110: 1045–1058
  • Steffens DC, Conway CR, Dombeck CB, Wagner HR, Tupler LA, Weiner RD. Severity of subcortical gray matter hyperintensity predicts ECT response in geriatric depression. The Journal of ECT 2001; 17: 45–49
  • Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke 1999; 30: 2159–2166
  • Steffens DC, Levy RM, Wagner R, et al. Socio-demographic and clinical predictors of mortality in geriatric depression. The American Journal of Geriatric Psychiatry 2002; 10: 531–540
  • Steffens DC, Taylor WD, Krishnan KR. Progression of subcortical ischemic disease from vascular depression to vascular dementia. American Journal of Psychiatry 2003; 160: 1751–1756
  • Stewart R, Prince M, Richards M, et al. Stroke, vascular risk factors and depression: Cross-sectional study in a UK Caribbean-born population. The British Journal of Psychiatry 2001; 178: 23–28
  • Taragano FE, Allegri R, Vicario A, Bagnatti P, Lyketsos CG. A double blind randomized clinical trial assessing the efficacy and safety of augmenting standard antidepressant therapy with nimodipine in the treatment of ‘vascular depression’. International Journal of Geriatric Psychiatry 2001; 16: 254–260
  • Taragano FE, Bagnatti P, Allegri RF. A double-blind, randomized clinical trial to assess the augmentation with nimodipine of antidepressant therapy in the treatment of ‘vascular depression’. International Psychogeriatrics 2005; 17: 487–498
  • Taylor WD, Steffens DC, MacFall JR, McQuoid DR, Payne ME, Provenzale JM, et al. White matter hyperintensity progression and late-life depression outcomes. Archives of General Psychiatry 2003; 60: 1090–1096
  • Thomas AJ, O’Brien JT, Davis S, Ballard C, Barber R, Kalaria RN, et al. Ischemic basis for deep white matter hyperintensities in major depression: A neuropathological study. Archives of General Psychiatry 2002; 59: 785–792
  • Thomas AJ, O’Brien JT, Barber R, McMeekin W, Perry R. A neuropathological study of periventricular white matter hyperintensities in major depression. Journal of Affective Disorders 2003; 76: 49–54
  • Thomas AJ, Kalaria RN, O’Brien JT. Depression and vascular disease: What is the relationship?. Journal of Affective Disorders 2004; 79: 81–95
  • Tupler LA, Krishnan KR, McDonald WM, Dombeck CB, D'Souza S, Steffens DC. Anatomic location and laterality of MRI signal hyperintensities in late-life depression. Journal of Psychosomatic Research 2002; 53: 665–676
  • Wade D, Legh-Smith J, Hewer R. Depressed mood after stroke: A community study of its frequency. British Journal of Psychiatry 1987; 151: 200–205
  • Whyte EM, Mulsant BH. Post-stroke depression: Epidemiology, pathophysiology, and biological treatment. Biological Psychiatry 2002; 52: 253–264
  • Wiart L, Petit H, Joseph PA, Mazaux JM, Barat M. Fluoxetine in early post-stroke depression: A double-blind placebo-controlled study. Stroke 2000; 31: 1829–1832

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.